Patients who have completed treatment intended to cure primary bile duct cancer should be followed-up every 3 months for the first year, thereafter every 6 months. The frequency and duration of follow-up is individual and based on the treatment modality. In patients having a non-curative treatment, the frequency should be according to the needs of the patient.
Follow-up of the patient should take place at the treatment center. After one year, if geographical conditions require, the follow-up can be performed at the patient's local hospital. Tests performed at follow-up:
- CT scan of liver (3 phase), possibly MRI
- Ultrasound of the liver, possibly with contrast
- MRCP, possibly ERCP
- CT scan of thorax
- Blood tests (liver tests and cancer markers, among others). Cancer markers (CEA, CA 19-9, AFP) may provide postoperative prognostic information in patients who had raised levels before treatment.
Transplant patients are included in Oslo University Hospital's separate follow-up arrangement after the transplant.